Literature DB >> 21439907

Dog models of naturally occurring cancer.

Jennie L Rowell1, Donna O McCarthy, Carlos E Alvarez.   

Abstract

Studies using dogs provide an ideal solution to the gap in animal models for natural disease and translational medicine. This is evidenced by approximately 400 inherited disorders being characterized in domesticated dogs, most of which are relevant to humans. There are several hundred isolated populations of dogs (breeds) and each has a vastly reduced genetic variation compared with humans; this simplifies disease mapping and pharmacogenomics. Dogs age five- to eight-fold faster than do humans, share environments with their owners, are usually kept until old age and receive a high level of health care. Farseeing investigators recognized this potential and, over the past decade, have developed the necessary tools and infrastructure to utilize this powerful model of human disease, including the sequencing of the dog genome in 2005. Here, we review the nascent convergence of genetic and translational canine models of spontaneous disease, focusing on cancer.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21439907      PMCID: PMC3130881          DOI: 10.1016/j.molmed.2011.02.004

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  66 in total

1.  Inactivation of p53 and retinoblastoma family pathways in canine osteosarcoma cell lines.

Authors:  R A Levine; M A Fleischli
Journal:  Vet Pathol       Date:  2000-01       Impact factor: 2.221

Review 2.  Cross talk from pets to people: translational osteosarcoma treatments.

Authors:  Stephen J Withrow; Ross M Wilkins
Journal:  ILAR J       Date:  2010

3.  Limb-sparing treatment for osteosarcoma in dogs.

Authors:  S M LaRue; S J Withrow; B E Powers; R H Wrigley; E L Gillette; P D Schwarz; R C Straw; S L Richter
Journal:  J Am Vet Med Assoc       Date:  1989-12-15       Impact factor: 1.936

4.  Copy number abnormalities in sporadic canine colorectal cancers.

Authors:  Jie Tang; Shoshona Le; Liang Sun; Xiuzhen Yan; Mucheng Zhang; Jennifer Macleod; Bruce Leroy; Nicole Northrup; Angela Ellis; Timothy J Yeatman; Yanchun Liang; Michael E Zwick; Shaying Zhao
Journal:  Genome Res       Date:  2010-01-19       Impact factor: 9.043

Review 5.  Genomic characteristics of soft tissue sarcomas.

Authors:  Fredrik Mertens; Ioannis Panagopoulos; Nils Mandahl
Journal:  Virchows Arch       Date:  2009-02-03       Impact factor: 4.064

Review 6.  Canine neoplasia--introductory paper.

Authors:  Hans Gamlem; Knut Nordstoga; Eystein Glattre
Journal:  APMIS Suppl       Date:  2008

Review 7.  The canine (dog) model of human aging and disease: dietary, environmental and immunotherapy approaches.

Authors:  Carl W Cotman; Elizabeth Head
Journal:  J Alzheimers Dis       Date:  2008-12       Impact factor: 4.472

8.  Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.

Authors:  H Fieten; B Spee; J Ijzer; M J Kik; L C Penning; J Kirpensteijn
Journal:  Vet Pathol       Date:  2009-05-09       Impact factor: 2.221

Review 9.  Spontaneous and genetically engineered animal models; use in preclinical cancer drug development.

Authors:  K Hansen; C Khanna
Journal:  Eur J Cancer       Date:  2004-04       Impact factor: 9.162

Review 10.  Next-generation gene targeting in the mouse for functional genomics.

Authors:  Yoichi Gondo; Ryutaro Fukumura; Takuya Murata; Shigeru Makino
Journal:  BMB Rep       Date:  2009-06-30       Impact factor: 4.778

View more
  138 in total

1.  Development and characterization of 5 canine B-cell lymphoma cell lines.

Authors:  Allison L Zwingenberger; William Vernau; Changying Shi; Wensheng Yan; Xinbin Chen; Ira K Gordon; Michael S Kent
Journal:  Leuk Res       Date:  2011-12-01       Impact factor: 3.156

2.  Translating cancer 'omics' to improved outcomes.

Authors:  Emily A Vucic; Kelsie L Thu; Keith Robison; Leszek A Rybaczyk; Raj Chari; Carlos E Alvarez; Wan L Lam
Journal:  Genome Res       Date:  2012-02       Impact factor: 9.043

Review 3.  Defining the Value of a Comparative Approach to Cancer Drug Development.

Authors:  Amy K LeBlanc; Christina N Mazcko; Chand Khanna
Journal:  Clin Cancer Res       Date:  2015-12-28       Impact factor: 12.531

4.  Body size, inbreeding, and lifespan in domestic dogs.

Authors:  Jennifer Yordy; Cornelia Kraus; Jessica J Hayward; Michelle E White; Laura M Shannon; Kate E Creevy; Daniel E L Promislow; Adam R Boyko
Journal:  Conserv Genet       Date:  2019-12-05       Impact factor: 2.538

5.  Immunohistochemical detection of p53, PTEN, Rb, and p16 in canine osteosarcoma using tissue microarray.

Authors:  Duncan S Russell; Lauren Jaworski; William C Kisseberth
Journal:  J Vet Diagn Invest       Date:  2018-04-09       Impact factor: 1.279

6.  A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma.

Authors:  Jennifer W Koehler; Andrew D Miller; C Ryan Miller; Brian Porter; Kenneth Aldape; Jessica Beck; Daniel Brat; Ingrid Cornax; Kara Corps; Chad Frank; Caterina Giannini; Craig Horbinski; Jason T Huse; M Gerard O'Sullivan; Daniel R Rissi; R Mark Simpson; Kevin Woolard; Joanna H Shih; Christina Mazcko; Mark R Gilbert; Amy K LeBlanc
Journal:  J Neuropathol Exp Neurol       Date:  2018-11-01       Impact factor: 3.685

7.  Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors.

Authors:  Janean Fidel; Katie C Kennedy; William S Dernell; Stacey Hansen; Valorie Wiss; Mark R Stroud; Joshua I Molho; Sue E Knoblaugh; Jeffrey Meganck; James M Olson; Brad Rice; Julia Parrish-Novak
Journal:  Cancer Res       Date:  2015-10-15       Impact factor: 12.701

8.  Suppression of canine myeloid cells by soluble factors from cultured canine tumor cells.

Authors:  J Wasserman; L Diese; Z VanGundy; C London; W E Carson; T L Papenfuss
Journal:  Vet Immunol Immunopathol       Date:  2011-12-28       Impact factor: 2.046

Review 9.  Domestic dogs and cancer research: a breed-based genomics approach.

Authors:  Brian W Davis; Elaine A Ostrander
Journal:  ILAR J       Date:  2014

10.  Non-immunosuppressive FTY720-derivative OSU-2S mediates reactive oxygen species-mediated cytotoxicity in canine B-cell lymphoma.

Authors:  R Mani; R Yan; X Mo; C-S Chen; M A Phelps; R Klisovic; J C Byrd; W C Kisseberth; C A London; N Muthusamy
Journal:  Vet Comp Oncol       Date:  2016-05-02       Impact factor: 2.613

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.